Associations between Liver Enzymes, Lifestyle Risk Factors and Pre-Existing Medical Conditions in a Population-Based Cross-Sectional Sample.

biomarker ethanol hypertension liver obesity physical activity

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
26 Jun 2023
Historique:
received: 27 04 2023
revised: 20 06 2023
accepted: 24 06 2023
medline: 14 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

While alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) enzymes are commonly used indicators of liver dysfunction recent studies have suggested that these may also serve as predictive biomarkers in the assessment of extrahepatic morbidity. In order to shed further light on the interactions between serum liver enzyme abnormalities, factors of lifestyle and health status we examined ALT and GGT activities in a population-based sample of 8743 adult individuals (4048 men, 4695 women from the National FINRISK 2002 Study, mean age 48.1 ± 13.1 years) with different levels of alcohol drinking, smoking, physical activity, body weight and the presence or absence of various pre-existing medical conditions. The assessments also included laboratory tests for inflammation, lipid status and fatty liver index (FLI), a proxy for fatty liver. The prevalence of ALT and GGT abnormalities were significantly influenced by alcohol use (ALT: p < 0.0005 for men; GGT:

Identifiants

pubmed: 37445311
pii: jcm12134276
doi: 10.3390/jcm12134276
pmc: PMC10342672
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : The Finnish Foundation for the Promotion of Laboratory Medicine
ID : 102014
Organisme : The Finnish Society of Clinical Chemistry
ID : 042018
Organisme : Competetive State Research Financing of the Expert Responsibility area of Seinäjoki and Tampere
ID : VTR53003116

Références

Diabet Med. 2006 Sep;23(9):1025-8
pubmed: 16922711
N Engl J Med. 2012 May 17;366(20):1891-904
pubmed: 22591295
Br J Sports Med. 2017 Apr;51(8):651-657
pubmed: 27581162
J Behav Med. 2012 Apr;35(2):200-10
pubmed: 21626151
Hypertens Res. 2023 Jan;46(1):119-127
pubmed: 36229524
BMC Gastroenterol. 2006 Nov 02;6:33
pubmed: 17081293
Gut. 2011 Aug;60(8):1152-8
pubmed: 21303916
EClinicalMedicine. 2022 May 12;48:101435
pubmed: 35706481
Front Psychiatry. 2017 Aug 28;8:160
pubmed: 28894426
Alcohol Clin Exp Res. 2016 Nov;40(11):2385-2393
pubmed: 27650665
Lancet. 2021 Sep 11;398(10304):957-980
pubmed: 34450083
J Am Heart Assoc. 2016 Sep 14;5(9):
pubmed: 27628571
PLoS One. 2013 May 07;8(5):e63439
pubmed: 23667618
Circulation. 2018 Jul 24;138(4):345-355
pubmed: 29712712
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861
pubmed: 35798021
Hepatology. 2009 Nov;50(5):1403-11
pubmed: 19670414
BMC Med. 2017 Nov 17;15(1):203
pubmed: 29145892
Front Psychol. 2022 Mar 18;13:856139
pubmed: 35369144
Hypertension. 2005 Nov;46(5):1186-93
pubmed: 16203871
Int J Environ Res Public Health. 2022 Nov 15;19(22):
pubmed: 36429766
BMJ. 2015 Aug 18;351:h4238
pubmed: 26286216
Alcohol Clin Exp Res. 2008 Dec;32(12):2081-7
pubmed: 18828805
Medicines (Basel). 2019 Mar 18;6(1):
pubmed: 30889791
Semin Liver Dis. 2020 May;40(2):154-162
pubmed: 32069503
Nature. 2000 Nov 9;408(6809):239-47
pubmed: 11089981
Clin Chem. 2003 Aug;49(8):1358-66
pubmed: 12881453
BMC Cardiovasc Disord. 2023 Mar 27;23(1):161
pubmed: 36973671
Addiction. 2013 Sep;108(9):1544-5
pubmed: 23947725
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20
pubmed: 28930295
Addiction. 2016 Feb;111(2):245-54
pubmed: 26359785
Mayo Clin Proc. 2019 Jun;94(6):985-994
pubmed: 31079962
Clin Chem. 2007 May;53(5):940-6
pubmed: 17384006
Gastroenterology. 1998 Apr;114(4):842-5
pubmed: 9547102
Clin Chem. 2017 Dec;63(12):1897-1898
pubmed: 28931518
Hepatology. 1990 May;11(5):843-9
pubmed: 1971805
Br J Cancer. 2010 Jun 29;103(1):90-3
pubmed: 20517309
BMJ Open. 2022 Jan 4;12(1):e049767
pubmed: 34983755
Hepatology. 2008 Mar;47(3):880-7
pubmed: 18302294
Liver Int. 2014 Apr;34(4):495-504
pubmed: 24102757
Circulation. 2005 Oct 4;112(14):2130-7
pubmed: 16186419
Am J Epidemiol. 2005 Jun 1;161(11):1081-8
pubmed: 15901629
BMC Med. 2014 Apr 07;12:59
pubmed: 24708705
Aliment Pharmacol Ther. 2009 Dec 1;30(11-12):1137-49
pubmed: 19737152
Gastroenterology. 2005 Jan;128(1):24-32
pubmed: 15633120
BMJ. 2018 Oct 24;363:k4168
pubmed: 30355576
PLoS Med. 2016 Aug 16;13(8):e1002082
pubmed: 27529741
PLoS One. 2019 Jun 20;14(6):e0218463
pubmed: 31220128
BMJ. 2018 Jul 18;362:k2817
pubmed: 30021785
Hepatology. 2008 Apr;47(4):1363-70
pubmed: 18366115
Prev Med. 2009 May;48(5):486-92
pubmed: 19254743
J Intern Med. 2018 Nov;284(5):534-545
pubmed: 29974563
Lancet. 2018 Apr 14;391(10129):1513-1523
pubmed: 29676281
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
Front Immunol. 2018 Apr 13;9:754
pubmed: 29706967
BMJ. 2017 Jun 6;357:j2353
pubmed: 28588063
Lancet Public Health. 2018 Mar;3(3):e124-e132
pubmed: 29475810
Hypertension. 2020 Feb;75(2):275-284
pubmed: 31865799
Free Radic Biol Med. 2012 Sep 15;53(6):1346-57
pubmed: 22819980
Scand J Gastroenterol. 2022 Mar;57(3):319-324
pubmed: 34874804
Mediators Inflamm. 2015;2015:514868
pubmed: 26538828
Subst Abus. 2015;36(3):318-24
pubmed: 25492554
Ann Oncol. 2013 Feb;24(2):301-308
pubmed: 22910838
Diabetes Obes Metab. 2022 Feb;24 Suppl 2:28-43
pubmed: 34324263
Liver Int. 2016 Dec;36(12):1723-1734
pubmed: 27512925
J Hepatol. 2017 Oct;67(4):829-846
pubmed: 28545937
Int J Cancer. 2008 Oct 15;123(8):1902-6
pubmed: 18688855
Hepatology. 2009 Mar;49(3):802-8
pubmed: 19152425
Eur Heart J. 2006 Sep;27(18):2170-6
pubmed: 16772340
Gastroenterology. 2009 Feb;136(2):477-85.e11
pubmed: 19100265
Hepatology. 2010 Sep;52(3):1156-61
pubmed: 20658466
Hepatology. 2010 Feb;51(2):482-90
pubmed: 19967717
Int J Epidemiol. 2018 Jun 1;47(3):696-696i
pubmed: 29165699
Lancet. 2016 Mar 5;387(10022):988-998
pubmed: 26343838
Cancer Res Treat. 2018 Apr;50(2):474-487
pubmed: 28546524
Hepatology. 2010 Feb;51(2):595-602
pubmed: 20014114
Gastroenterology. 2008 Dec;135(6):1851-4
pubmed: 19007778
Nutrients. 2022 Oct 27;14(21):
pubmed: 36364789
Am J Gastroenterol. 2003 May;98(5):960-7
pubmed: 12809815
Diabetes Care. 2007 Aug;30(8):2119-21
pubmed: 17519430
Circulation. 2005 Oct 4;112(14):2078-80
pubmed: 16203922
Hypertens Res. 2023 Apr;46(4):896-897
pubmed: 36750611
Am J Respir Cell Mol Biol. 2009 Nov;41(5):509-15
pubmed: 19684307
Aliment Pharmacol Ther. 2015 Mar;41(5):467-76
pubmed: 25588768
Hepatology. 2015 Apr;61(4):1205-15
pubmed: 25271091
Nutrients. 2022 Jun 08;14(12):
pubmed: 35745100
Hepatology. 2012 May;55(5):1406-15
pubmed: 22334565
J Clin Invest. 2019 Mar 1;129(3):944-945
pubmed: 30688662
Lancet Diabetes Endocrinol. 2014 Nov;2(11):901-10
pubmed: 24731669
BMJ. 2016 Aug 09;354:i3857
pubmed: 27510511
Eur J Epidemiol. 2013 May;28(5):361-72
pubmed: 23532745
Hypertension. 2016 Nov;68(5):1208-1216
pubmed: 27672023
Am J Clin Nutr. 2008 Oct;88(4):1097-103
pubmed: 18842799
Diabetes Care. 2009 Apr;32(4):741-50
pubmed: 19131466
PLoS One. 2017 Dec 5;12(12):e0188574
pubmed: 29206836
Circ Res. 2015 Mar 13;116(6):991-1006
pubmed: 25767285
Hepatology. 2009 Jul;50(1):68-76
pubmed: 19444870

Auteurs

Onni Niemelä (O)

Department of Laboratory Medicine and Medical Research Unit, Seinäjoki Central Hospital and Tampere University, 60220 Seinäjoki, Finland.

Aini Bloigu (A)

Research Unit of Population Health, Faculty of Medicine, University of Oulu, 90014 Oulu, Finland.

Risto Bloigu (R)

Infrastructure for Population Studies, Faculty of Medicine, University of Oulu, 90014 Oulu, Finland.

Mauri Aalto (M)

Department of Psychiatry, Seinäjoki Central Hospital and Tampere University, 33100 Tampere, Finland.

Tiina Laatikainen (T)

Department of Public Health and Social Welfare, Finnish Institute for Health and Welfare (THL), 00271 Helsinki, Finland.
Institute of Public Health and Clinical Nutrition, University of Eastern Finland, 70211 Kuopio, Finland.
Joint Municipal Authority for North Karelia Social and Health Services, 80210 Joensuu, Finland.

Classifications MeSH